Medicine Atlas

How Healing Is Practiced
Sign In
Text size
100%
Theme
Condition

Waldenstrom Macroglobulinemia

Neoplasms

Waldenstrom macroglobulinemia is a cancer affecting two types of white blood cells, lymphoplasmacytoid cells and plasma cells, characterized by high levels of a circulating antibody, immunoglobulin M, produced and secreted by the cells involved. It is considered an indolent lymphoma and a type of lymphoproliferative disease that shares clinical features with the indolent non-Hodgkin lymphomas, and it is commonly classified as a form of plasma cell dyscrasia, similar to other plasma cell dyscrasias such as those that lead to multiple myeloma. It is commonly preceded by two clinically symptom free but progressively more premalignant phases, IgM monoclonal gammopathy of undetermined significance and smoldering Waldenstrom macroglobulinemia.

Facts
Classification
Body System
Lymphatic or Immune System 1
ICD-10 Chapter
II: Neoplasms 2
Communicable or Non-communicable
Non-Communicable 3
Transmission Route
Non-Transmissible 1
Sources
1. Waldenstrom macroglobulinemia (Wikipedia)
  • Lead section, body-system statement
    It is characterized by having high levels of a circulating antibody, immunoglobulin M (IgM), which is made and secreted by the cells involved in the disease.
  • Lead section, transmission-route statement
    Waldenström macroglobulinemia ( VAL-dən-strom MAK-roh-GLOB-yə-lin-EE-mee-ə, US also VAHL-dən-strem -⁠) is a type of cancer affecting two types of white blood cells: lymphoplasmacytoid cells and plasma cells (both B cells).
View the Source
2. Wikipedia: ICD-10
WikipediaList of chapters, Chapter II
Quote, List of chapters, Chapter II
Neoplasms
View the Source
3. World Health Organization: Noncommunicable diseases (fact sheet)
World Health OrganizationMain Types section
Quote, Main Types section
The main types of NCDs are cardiovascular diseases (such as heart attacks and stroke), cancers, chronic respiratory diseases (such as chronic obstructive pulmonary disease and asthma) and diabetes.
View the Source
Comments (0)
No comments yet. Be the first to share a thought.
Reader Challenges (0)
No disputes yet. Spotted an error or a better source? Open the first one.